4:03 PM Abstract No. 88 Retrospective analysis of second-line Y-90 compared to 1st line Y-90 in patients with nonresectable hepatocellular carcinoma

A. Reposar; N. Hoang; M. Khalaf; M. AbdelRazek; D. Katz; D. Wang; J. Louie; D. Sze

首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >4:03 PM Abstract No. 88 Retrospective analysis of second-line Y-90 compared to 1st line Y-90 in patients with nonresectable hepatocellular carcinoma

【24h】

4:03 PM Abstract No. 88 Retrospective analysis of second-line Y-90 compared to 1st line Y-90 in patients with nonresectable hepatocellular carcinoma

机译：下午4:03摘要88号临时y-90回顾性分析与非可爱肝细胞癌患者的第一线Y-90相比

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of vascular and interventional radiology: JVIR 》 |2018年第4suppla期| 共1页
作者
A. Reposar; N. Hoang; M. Khalaf; M. AbdelRazek; D. Katz; D. Wang; J. Louie; D. Sze;
展开▼
作者单位

Stanford University Medical Center;

Stanford University;

Stanford University Medical Center;

Stanford University Medical Center;

Stanford University Medical Center;

Stanford Unveristy School of Medicine;

Stanford University;

Stanford University Medical Center;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学 ;
关键词

相似文献

外文文献
专利

1. 4:03 PM Abstract No. 88 Retrospective analysis of second-line Y-90 compared to 1st line Y-90 in patients with nonresectable hepatocellular carcinoma [J] . A. Reposar, N. Hoang, M. Khalaf, Journal of vascular and interventional radiology: JVIR . 2018 ,第4Suppla期

机译：下午4:03摘要88号临时y-90回顾性分析与非可爱肝细胞癌患者的第一线Y-90相比
2. 4:03 PM Abstract No. 40 Comparative analysis of the safety of TACE for the treatment of hepatocellular carcinoma in patients with and without TIPS [J] . M. Chiarello, E. Aaltonen, M. McDermott Journal of vascular and interventional radiology: JVIR . 2018 ,第4Suppla期

机译：下午4:03 PM摘要40号TACE治疗肝细胞癌患者肝细胞癌安全性的40号比较分析
3. 3:36 PM Abstract No. 37 Retrospective analysis of 30-60μm and 50-100μm HepaSphere drug-eluting beads doxorubicin (DEBDOX) embolization in BCLC B patients with non-resectable hepatocellular carcinoma: preliminary results [J] . B. Maher, D. Klass, F. Chou, Journal of vascular and interventional radiology: JVIR . 2018 ,第4Suppla期

机译：下午3:36摘要37次回顾性分析30-60μm和50-100μm的药物洗脱珠子多柔比星（Debdox）栓塞在BCLC B中的非可折心肝细胞癌患者：初步结果
4. Betatrophin Expression in Chronic Hepatitis C Patients: Does Contribute to Liver Injury-linked Metabolic Syndrome and Hepatocellular Carcinoma Development? [C] . Hendra Susanto, Nan-Shan Liou, Bogi Pratomo, International Conference on Life Sciences and Technology . 2020

机译：慢性丙型肝炎患者的BERATROPHIN表达：是否有助于肝损伤链接代谢综合征和肝细胞癌发育？
5. Development of dose response to Y-90 microsphere treatment of metastatic liver cancer by quantitative analysis of SPECT and PET images . [D] . Campbell, Janice M. 2008

机译：通过SPECT和PET图像定量分析建立Y-90微球治疗转移性肝癌的剂量反应。
6. Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials [O] . Dongxu Wang, Xu Yang, Jianzhen Lin, 2020

机译：比较肝细胞癌二线疗法的疗效和安全性：III期试验的网络荟萃分析
7. Abstract No. 517 Cheaper isn’t always cheapest:cost analysis of Y-90 vs transarterial chemoembolization for treatment of hepatocellular carcinoma [O] . A. Desai, B. McCabe, B. Natarajan 2019

机译：摘要517便宜并不总是最便宜的：Y-90 VS Cranterial Chearoembolization治疗肝细胞癌的成本分析

4:03 PM Abstract No. 88 Retrospective analysis of second-line Y-90 compared to 1st line Y-90 in patients with nonresectable hepatocellular carcinoma

著录项

相似文献

相关主题

期刊订阅